Skip to content
  • Sunday, 26 July 2026
  • 2:52 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Hydrogen Sulfide and CSE Protein Research Offers New Therapeutic Target for Alzheimer’s Disease Treatment and Brain Health
Neuroscience & Brain Research

Hydrogen Sulfide and CSE Protein Research Offers New Therapeutic Target for Alzheimer’s Disease Treatment and Brain Health

Rifan Muazin Apr 17, 2026 0

Researchers at Johns Hopkins Medicine have announced that a newly funded study by the National Institutes of Health (NIH) is…

Read More
Neuroscience & Brain Research

Johns Hopkins Researchers Identify Brain Protein Producing Hydrogen Sulfide as Potential Target for Alzheimer’s Treatment

Rifan Muazin Apr 10, 2026 0

Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the quest to understand and eventually treat Alzheimer’s disease,…

Read More
Pharmaceutical R&D

Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion

Teuku Ryan Apr 10, 2026 0

Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…

Read More
Neuroscience & Brain Research

UCSF Researchers Identify FTL1 Protein as Master Regulator of Hippocampal Aging and Potential Target for Reversing Memory Loss

Rifan Muazin Apr 5, 2026 0

The human brain is an intricate network of billions of neurons, yet its functional integrity is famously fragile, particularly within…

Read More
Molecular & Cell Biology

Unraveling the Malaria Parasite’s Molecular Choreography: A Specialized Protein Emerges as a Potent Drug Target

Angie Faith Mar 30, 2026 0

Researchers from a consortium of leading international institutions have unveiled groundbreaking insights into the intricate mechanisms governing the growth and…

Read More
Neuroscience & Brain Research

Molecular Breakthrough in Alzheimers Pathology Reveals Neurotoxic Death Complex as Key Therapeutic Target

Rifan Muazin Mar 23, 2026 0

A collaborative research effort led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University’s Interdisciplinary Center for Neurosciences (IZN) has…

Read More
Molecular & Cell Biology

Unlocking Malaria’s Secrets: Novel Protein ARK1 Emerges as a Crucial Target for Future Antimalarial Therapies

Angie Faith Mar 23, 2026 0

Researchers from a consortium of leading international institutions have unveiled groundbreaking insights into the intricate life cycle of the malaria…

Read More
Neuroscience & Brain Research

Washington University Researchers Develop Single Injection Cellular Immunotherapy to Target Alzheimer’s Disease Amyloid Plaques

Rifan Muazin Mar 20, 2026 0

The landscape of neurodegenerative disease research has reached a pivotal turning point as scientists move beyond symptom management toward therapies…

Read More
Biotech & Genetic Research

Bugs deliver drugs: weaponizing bacteria to target colorectal cancer therapy

Jia Lissa Mar 19, 2026 0

A groundbreaking scientific endeavor, spearheaded by a collaborative team of researchers from Baylor University (TX, USA), Texas Tech University Health…

Read More

Posts pagination

1 2
Ludwig Cancer Research Study Reveals Novel Combination Therapy to Overcome Differentiation Blockade in Acute Myelogenous LeukemiaDiscovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis TreatmentOverlooked microtubules unravel mysteries of female fertilityMitochondrial Energy Restoration Offers Potential Breakthrough in Addressing Cognitive Decline and Dementia Progression
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ